Jump Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Jump Financial’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,983	Closed	-$87K	–	1246
2020 Q3	$87K	Buy	+14,983	New	+$89.6K	0.02%	703

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's CLVS Position: Q4 2020 in Review

Jump Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 14,983 shares — an estimated $87K sold.

Jump Financial first reported a position in CLVS in Q3 2020 and held it in 1 quarter. The position peaked at $87K in Q3 2020. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

Jump Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
Jump Financial sold 14,983 Clovis Oncology, Inc. shares in Q4 2020, an estimated $87K.
Jump Financial first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 1 quarter.
Jump Financial's Clovis Oncology, Inc. position peaked at $87K in Q3 2020.
159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Jump Financial's 13F filing for Q4 2020, filed 12 Feb 2021.